Biology Reference
In-Depth Information
47. Theas S, De Laurentiis A, Candolfi M, López SL, Carrasco AE, Zaldivar V, et al. Nitric
oxide mediates the inhibitory effect of tumor necrosis factor-alpha on prolactin release.
Neuroendocrinology 2001;74(2):82-6.
48. Barbieri F, Bajetto A, Porcile C, Pattarozzi A, Schettini G, Florio T. Role of stromal cell-
derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. J Mol Endoc-
rinol 2007;38(3):383-89.
49. Francis K, Lewis BM, Akatsu H, Monk PN, Cain SA, Scanlon MF, et al. Complement C3a
receptors in the pituitary gland: a novel pathway by which an innate immune molecule
releases hormones involved in the control of inflammation. FASEB J 2003;17(15):2266-68.
50. Markianos M, Kosmidis ML, Sfagos C. Reductions in plasma prolactin during acute ery-
thropoietin administration. Neuro Endocrinol Lett 2006;27(3):355-58.
51. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cyto-
kines, and autoimmunity. Ann NY Acad Sci 2002;966:290-303.
52. Buller KM. Central pathways of immunoregulation. In: Arnason BG, Berczi I, editors;
Berczi I, series editor. The brain and host defense. Neuroimmune biology, vol. 9. Amster-
dam: Elsevier; 2010.
53. Besedovsky HO, del Rey A. The cytokine-HPA axis feed-back circuit. Z Rheumatol
2000;59(Suppl. 2). II/26-30.
54. Conti B, Tabarean I, Sanchez-Alavez M, Davis C, Brownell S, Behrens M, et al.
Cytokine receptors in the brain. In: Phelps C, Korneva EA, editors; Berczi I, Szentivanyi A,
series editors. Cytokines and the brain. Neuroimmune biology, vol. 6. Amsterdam:
Elsevier; 2008. p. 21-38.
55. Flo T, Aderen A. Pathogen recognition by toll-like receptors. In: Bertok L, Chow DA, edi-
tors; Berczi I, Szentivanyi A, series editors. Natural immunity. Neuroimmune biology, vol.
5. Amsterdam: Elsevier; 2005. p. 167-82.
56. Iwasaki Y, Taguchi T, Nishiyama M, Asai M, Yoshida M, Kambayashi M, et al.
Lipopolysaccharide stimulates proopiomelanocortin gene expression in AtT20 corti-
cotroph cells. Endocr J 2008;55(2):285-90.
57. Bornstein SR, Ziegler CG, Krug AW, Kanczkowski W, Rettori V, McCann SM, et al.
The role of toll-like receptors in the immune-adrenal crosstalk. Ann NY Acad Sci 2006;
1088:307-18.
58. Katsargyris A, Klonaris C, Alexandrou A, Giakoustidis AE, Vasileiou I, Theocharis S. Toll
like receptors in liver ischemia reperfusion injury: a novel target for therapeutic modu-
lation? Expert Opin Ther Targets 2009;13(4):427-42.
59. Shang L, Fukata M, Thirunarayanan N, Martin AP, Arnaboldi P, Maussang D, et al. Toll-
like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA
production in lamina propria. Gastroenterology 2008;135(2):529-38.
60. Curtiss LK, Tobias PS. Emerging role of toll-like receptors in atherosclerosis. J Lipid Res
2009;50(Suppl.):S340-45.
61. Heo SK, Yun HJ, Noh EK, Park WH, Park SD. LPS induces inflammatory responses in
human aortic vascular smooth muscle cells via toll-like receptor 4 expression and nitric
oxide production. Immunol Lett 2008;120(1-2):57-64.
62. Pearlman E, Johnson A, Adhikary G, Sun Y, Chinnery HR, Fox T, et al. Toll-like recep-
tors at the ocular surface. Ocul Surf 2008;6(3):108-16.
63. Quintanar-Stephano A, Villalobos C, Gonzales E, Organista A, Tinajero M, Chavira R,
et al. Role of the neurohypophysis on spleen cytokine MRNA expression and macrophage
number in AIA. In: Abstract No. A3, Proc. VII. INSNIM congress. Rio de Janeiro; 2008. p. 34.
64. Bertók L. New prospect for the enhancement of natural immunity. In: Bertk L, Chow DA.
editors; Berczi I, Szentivanyi A, series editor. Natural immunity. Neuroimmune biology,
vol. 5. Amsterdam: Elsevier; 2005. p. 289-307.
